Evaluation of NanoDoce ® in Participants With Urothelial Carcinoma

Conditions:   Bladder Cancer;   Urothelial Carcinoma;   Urinary Bladder Neoplasm;   Urinary Bladder Cancer;   Urogenital Neoplasms;   Urologic Neoplasms;   Urologic Cancer;   Malignant Tumor of the Urinary Bladder;   Cancer of the Bladder Interventions:   Drug: NanoDoce (direct injection);   Drug: NanoDoce (intravesical instillation);   Other: Institutional Standard of Care Sponsors:   NanOlogy, LLC;   US Biotest, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials